HIV-1 (co)Receptors: Implications for Vaccine and Therapy Design

Publisher： Bentham Science Publishers

E-ISSN： 1873-4286|16|33|3701-3715

ISSN： 1381-6128

Source： Current Pharmaceutical Design, Vol.16, Iss.33, 2010-11, pp. : 3701-3715

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

HIV Co-receptors as Targets for Antiviral Therapy

By  

Current Topics in Medicinal Chemistry, Vol. 4, Iss. 9, 2004-05 ,pp. : 883-893

Bentham Science Publishers

Access to resources Recommend Favorite

Antibody responses and virus escape: implications for HIV-1 vaccine and therapeutic design

By Tomaras Georgia   Shen Xiaoying   Greenberg Michael  

Future Virology, Vol. 1, Iss. 1, 2006-01 ,pp. : 79-88

Future Medicine

Access to resources Recommend Favorite

The use of Envelope for HIV therapeutics: from vaccines to co-receptors

By Doranz B.J.  

Expert Opinion on Therapeutic Targets, Vol. 4, Iss. 4, 2000-08 ,pp. : 423-437

Informa Healthcare

Access to resources Recommend Favorite

Progress in Studies of Structure, Mechanism and Antagonists Interaction of GPCR Co-Receptors for HIV

By  

Current Pharmaceutical Biotechnology, Vol. 15, Iss. 10, 2014-10 ,pp. : 938-950

Bentham Science Publishers

Access to resources Recommend Favorite

HIV-1 superinfection - implications for vaccine development

By  

Inpharma, Vol. 1, Iss. 1355, 2002-01 ,pp. : 12-12

Adis International

Access to resources Recommend Favorite